Objective: To compare the safety and efficacy of Misoprostol with Oxytocin for management of third stage of labor.
Methodology: This randomized control trial was conducted at Department of Gynecology and Obstetrics, Cantonment General Hospital, Rawalpindi, Pakistan from May to Oct 2015. A total of 212 singleton pregnant women were selected. Women were allocated to either group using simple computer generated randomization table. Group I received 10 U intramuscular Oxytocin while group II received 600ug sublingual Misoprostol. Primary outcome measures were severity of primary postpartum hemorrhage, amount of blood loss and side effects of drugs.
Results: The mean blood loss was 303.50+225.35 in group I and 271.30+206.205 in group II (p=0.035). The average drop in hemoglobin was 0.84+0.78 in group I and 0.81+0.79 in group II (p=0.980). There is no association in two groups with regard to PPH, repeat dose, complications and blood transfusion (p=0.86).
Conclusion: Misoprostol was better than Oxytocin regarding average blood loss for the management of third stage of labor.
Misoprostol, Oxytocin, Prevention, Postpartum hemorrhage.
Leukoaraiosis is associated with clinical symptom severity, poor neurological function prognosis and stroke recurrence in mild intracerebral hemorrhage: a prospective multi-center cohort study.
Xu TQ, Lin WZ, Feng YL, Shen FX, Chen J, Wu WW, Zhu XD, Gu L, Fu Y
Neural regeneration research. 2022; 17(4): 819-823
The effectiveness and safety of complementary health approaches to managing postpartum pain: A systematic review and meta-analysis.
Smith CA, Hill E, Denejkina A, Thornton C, Dahlen HG
Integrative medicine research. 2022; 11(1): 100758
Intracerebral Delivery of an OTR Antagonist and Subsequent Behavioral Testing in Prairie Voles.
Hirota Y, Otsuki C, Kamura E, Mitsui S
Methods in molecular biology (Clifton, N.J.). 2022; 2384(): 257-269
Use of Cocultures to Measure the Blood-Brain Barrier Permeability of Oxytocin.
Yamamoto Y, Harashima A, Munesue SI, Higashida H
Methods in molecular biology (Clifton, N.J.). 2022; 2384(): 247-255
Measuring Affinity of Ligands to the Oxytocin Receptor Using Radioligand Binding.
Werry EL, Kassiou M
Methods in molecular biology (Clifton, N.J.). 2022; 2384(): 231-245